Amanda Verpoorte
About Amanda Verpoorte
Amanda Verpoorte serves as the Medical Innovation Strategy Director at SOPHiA GENETICS, where she has worked since 2020. She holds a PhD in Bioengineering from EPFL and has a diverse background in strategic planning and research within the medical field.
Work at SOPHiA GENETICS
Amanda Verpoorte serves as the Medical Innovation Strategy Director at SOPHiA GENETICS, a position she has held since 2020. In this role, she focuses on strategic initiatives that drive medical innovation within the organization. SOPHiA GENETICS specializes in data-driven medicine, leveraging advanced analytics to enhance patient care. Verpoorte's expertise in bioengineering and strategic innovation contributes to the company's mission of transforming healthcare through genomic data.
Education and Expertise
Amanda Verpoorte has a robust educational background in bioengineering. She earned her Doctor of Philosophy (PhD) from École polytechnique fédérale de Lausanne (EPFL) between 2012 and 2017. Prior to her PhD, she completed a Master of Science (MS) in Bioengineering at EPFL from 2009 to 2011, and a Bachelor of Science (BS) in Life Sciences and Technologies from 2006 to 2009. Additionally, she conducted her master thesis at Imperial College London in Bioengineering and Biomedical Engineering from 2010 to 2011.
Background
Amanda Verpoorte's early education includes attending the International School of Geneva, where she achieved Maturité Fédérale from 2003 to 2006. Following her academic pursuits, she gained professional experience at various organizations, including McKinsey & Company as an Associate from 2018 to 2020, and as a Scientist at EPFL for eight months in 2017. She also worked as a Strategic Planning Trainee at Pictet Wealth Management for six months in 2018.
Achievements
In addition to her role at SOPHiA GENETICS, Amanda Verpoorte leads the Emmy Noether Research Group at the Max-Planck Institute for Terrestrial Microbiology. Her leadership in this research group reflects her strong background in bioengineering and her commitment to advancing strategic innovation in the medical field. Verpoorte's analytical skills and adaptability are key assets in her professional endeavors.